logo-loader
RNS
Tate & Lyle PLC

Tate & Lyle PLC - Directorate Change

RNS Number : 3843C
Tate & Lyle PLC
27 March 2025
 

27 March 2025

 

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") is pleased to announce that Steve Foots will join the Board as a non-executive director and as a member of the Remuneration and Nominations Committees from  the conclusion of the Annual General Meeting which is to be held on 24 July 2025 (the "AGM"), subject to his election at the AGM.

 

Steve is Chief Executive of Croda International Plc, the FTSE100 speciality ingredients business that uses smart science to create high-performance ingredients and solutions that improve lives, a position he has held since 2012.  He joined Croda as a graduate trainee in 1990 and during his career with the company has held a number of senior management positions including President of Croda Europe from 2010.  He also serves as the co-Chair of the Chemistry Council, the joint Government / industry sector council for the chemical industry in the UK.

 

The Company also announces that Lars Frederiksen, an independent non-executive director, will retire from the Board from the conclusion of the AGM after serving for a full nine-year term. Lars has served on the Board since April 2016 and was a member of the Remuneration and Nominations Committees.

 

David Hearn, Chair of Tate & Lyle, said: "I am delighted that Steve has agreed to join the Board. His strategic and operational leadership experience, and deep understanding of the importance of customer focus and innovation, will be of significant benefit to the Board as we deliver on Tate & Lyle's growth agenda. I am also very appreciative of the significant contribution that Lars has made to the success of Tate & Lyle during his time with the business and we wish him well for the future."

 

There are no further disclosures to be made in connection with Mr Foots' appointment pursuant to paragraph 6.4.8 of the Financial Conduct Authority's Listing Rules.

 

 

For more information contact Tate & Lyle PLC:

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

Tel: Office: +44 (0) 203 727 1340

Email: tate@fticonsulting.com

 

About Tate & Lyle PLC:

 

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

 

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEEFWMEISEID
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Form 8.3 - Tate & Lyle plc

5 hours, 52 minutes ago

Form 8.3 - Tate & Lyle

6 hours, 35 minutes ago

Form 8.3 - Tate & Lyle plc

7 hours, 16 minutes ago

Form 8.3 - Tate & Lyle plc

8 hours, 26 minutes ago

Form 8.3 - Tate & Lyle plc

8 hours, 33 minutes ago

Form 8.3 Tate & Lyle Plc

8 hours, 42 minutes ago

Form 8.3 - Tate & Lyle plc

8 hours, 54 minutes ago

4 min read